IMMUNO-BIOMAP: Immunotherapy Biomarker Collection for Metastatic NSCLC to inform Adaptive Personalized models targeting resistance
Beckman Research Institute of the City of Hope (lung cancer): The team will create a biomap of immunotherapy resistance mechanisms in non-small cell lung cancer and validate new biomarker-guided therapy in near real-time to improve the success of patient treatments.